Pharmagate and the Economics of Patent Law Reform

[Marcus Low, Treatment Action Campaign, Link (CC-BY-SA)] We are deeply perturbed by revelations in last Friday’s Mail & Guardian exposing what appears to be a very well-funded, covert plot by foreign pharmaceutical companies and their local subsidiaries to delay a democratic law reform process in South Africa. The law reform concerns the new draft intellectual [...]